Filing Details
- Accession Number:
- 0001477932-21-004848
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-22 20:54:06
- Reporting Period:
- 2021-07-20
- Accepted Time:
- 2021-07-22 20:54:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1187953 | Creative Medical Technology Holdings Inc. | CELZ | Biological Products, (No Disgnostic Substances) (2836) | 870622284 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1429928 | Thomas Ichim | 211 E. Osborn Rd Phoenix AZ 85012 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-07-20 | 1,400,000 | $0.03 | 7,479,522 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-07-21 | 1,500,000 | $0.03 | 5,979,522 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-07-22 | 1,450,000 | $0.03 | 4,529,522 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 17,245 | Indirect | By LLC |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.03 to $0.030521, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.031. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.0305. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.
- Shares are held by BioTech Holdings, LLC, of which the reporting person is President. The reporting person disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
